Today Trend status: Mature/Declining
Neurochem Int 128:94105 Davies M, Faerch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Liquid formulas: Water-based suspensions are more prone to microbial growth and separation if not kept cold
Dietary, nutritional and botanical influences on glutathione are presented
This would be particularly helpful for those with conditions like type 2 diabetes or high cholesterol
UK clinics and patients now have substantial real-world experience with prescribing, titration, and follow-up, alongside the original evidence from the STEP programme and ongoing use in practice